Purchase Order HHSN271201700676P
- Not listed
- This is a federal contract award to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables that provides a wide range of products and services to support biomedical research, applied markets, and forensic analysis for the federal government. The contract, valued at $17,987.20, was awarded by the National Institutes of Health (NIH) Clinical Center on May 21, 2018 and has an ultimate completion date of June 30, 2019. The contract is a Firm Fixed Price...
- This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The $91,545.00 firm fixed-price purchase order is for the delivery of assorted cell consumables. The contract has no set-aside designation. Life Technologies Corporation, a division of Thermo Fisher Scientific, has...
- This is a $142,497.17 firm fixed-price purchase order awarded to Life Technologies Corporation by the National Institute on Drug Abuse, a civilian agency within the U.S. Department of Health and Human Services. The contract supports the delivery of scientific instruments, reagents, and consumables to enable biomedical research, applied markets, and forensic analysis for the federal government. Life Technologies serves as a prime contractor across multiple agencies, including the National...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract has a potential value of $13,377.00 and no set-aside designation. Life Technologies Corporation, a division of Thermo Fisher Scientific, provides specialized biotechnology products to support federal...
- This federal contract award is for the provision of reagents and consumables from Life Technologies Corporation to the National Institutes of Health (NIH) Clinical Center. The $12,004.54 Firm Fixed Price purchase order was awarded on September 18, 2025 with an ultimate completion date of October 18, 2025. The contract does not utilize a small business set-aside. Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc., is a leading provider of biomedical research and...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $17,943.68 firm fixed price contract was awarded on August 22, 2018 with a completion date of August 22, 2019. The contract did not utilize a set-aside designation. As a subsidiary of Thermo Fisher Scientific, Life...
- This firm-fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $236,257.60 contract is for the delivery of products and services to support the agency's biomedical research, applied markets, and forensic analysis initiatives. Life Technologies has provided genetic...
- This is a federal purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $4,453.78 firm fixed-price contract is for the delivery of products and services to support the agency's biomedical research, applied markets, and forensic analysis initiatives. As a division...
- Life Technologies Corporation was awarded a $398,130 firm fixed price delivery order by the National Institutes of Health's National Institute on Drug Abuse to support the generation of induced pluripotent stem cell lines. As a prime contractor, Life Technologies will leverage its expertise in genetic sequencing and sample preparation to deliver specialized biotechnology products and services under this contract. No set-aside provisions were specified. Life Technologies currently holds three...
- This federal contract award to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, is a Firm Fixed Price Purchase Order from the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract, which does not have a set-aside designation, has a potential value of $17,110.91 and a completion date of April 16, 2024. As a prime contractor, Life Technologies Corporation...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Firm Fixed Price Purchase Order worth $106,172.66 to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The contract has a completion date of February 28, 2019 and does not utilize any set-asides. As a division of Thermo Fisher Scientific, Life Technologies has delivered genetic analyzers, reagents, assays, instruments, and associated repair services to enable federal initiatives related to healthcare, medical readiness, and biomedical research across multiple agencies. The contract award suggests Life Technologies is a prime contractor for the NIH, providing specialized biotechnology products and services to support the agency's research and healthcare missions. No additional details on a larger contract vehicle or subcontractors were provided.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Funding Only Action | ($833) | 12/6/21 | |
| 2 | Other Administrative Action | $0 | 4/25/18 | |
| 1 | Other Administrative Action | $0 | 12/21/17 | |
| Not listed | Not listed | $107.0k | 9/22/17 |